The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...

HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...

Lower-income countries, including South Africa, gain unprecedented access to lenacapavir, a revolutionary HIV prevention drug ...

A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...

Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.

Africa Check has debunked viral social media claims about an HIV “cure”, clarifying that the breakthrough is promising, but ...